Andrew Feldstein

Co-Chief Investment Officer and Chief Executive Officer

Andrew Feldstein is the CEO and Co-CIO of BlueMountain Capital Management. Mr. Feldstein is the Chair of the Firm’s Management Committee and a member of the Investment and Risk Committees. Prior to co-founding BlueMountain in 2003, Mr. Feldstein spent over a decade at J.P. Morgan where he was a Managing Director and served as Head of Structured Credit; Head of High Yield Sales, Trading and Research; and Head of Global Credit Portfolio. Mr. Feldstein is a member of the board of directors of PNC Financial Services Group Inc. He is also a Trustee of Third Way, a public policy think tank; a Trustee of the Santa Fe Institute, an independent research and education center; and a member of the Harvard Law School Leadership Council. Mr. Feldstein holds a J.D. from Harvard Law School and a B.A. from Georgetown University.

Stephen Siderow

Co-Founder, Managing Partner and Co-President

Stephen Siderow is the Co-founder, Managing Partner and Co-President of BlueMountain Capital Management. At BlueMountain, he oversees the Firm’s business development and strategic initiatives. Mr. Siderow is also a member of the Firm’s Management and Compliance Committees. Prior to co-founding BlueMountain in 2003, Mr. Siderow was a Senior Consultant with McKinsey & Company’s New York Office, where he focused on the financial services industry, serving senior management executives and CEOs on a variety of issues in business strategy, organization and operations. Prior to that, Mr. Siderow was a Corporate Attorney with Cleary, Gottlieb in New York. Mr. Siderow serves on the Board of Directors of the Birthright Israel Foundation, a program that provides the gift of first-time peer education trips to Israel for young Jewish adults. Mr. Siderow serves on the Board of Directors of Ars Nova, which provides training and development programs to young performing artists. Mr. Siderow is also a member of the Advisory Board of the Hertzberg Palliative Care Institute at Mt. Sinai Hospital whose mission is to advance the field of palliative medicine through clinical, educational and research initiatives. Mr. Siderow holds a J.D. cum laude from Harvard Law School and Bachelor’s degree, magna cum laude, in Philosophy from Amherst College. Mr. Siderow was also a Fulbright and a Sheldon Scholar in Israel.

Alan Gerstein

Managing Partner

Alan Gerstein is a Managing Partner at BlueMountain. Mr. Gerstein is also a member of the Firm’s Management and Risk Committees and Chair of the Valuation Committee. Prior to joining BlueMountain in 2004, Mr. Gerstein was a Vice President and Head of U.S. Investment Grade Credit Derivatives Trading at Goldman Sachs. Over a 10 year career at Goldman, Mr. Gerstein held several other senior positions including Head of U.S. Agency Bond Trading and in Interest Rate Derivatives Marketing. Prior to that, Mr. Gerstein was a Vice President of Interest Rate Derivatives Marketing at J.P. Morgan, where he worked with Mr. Feldstein. Mr. Gerstein is a member of the Board of Trustees at Blythedale Children’s Hospital in Valhalla, NY. Mr. Gerstein holds an M.B.A. from the MIT Sloan School of Management and B.S. in Economics from the Massachusetts Institute of Technology.

Bryce Markus

Chief Financial Officer, Chief Risk Officer, and Co-President

Bryce Markus is a Managing Partner, Chief Financial Officer, Chief Risk Officer and Co-President of BlueMountain. Mr. Markus is also a member of the Firm’s Investment and Management Committees and Chair of the Risk Committee. Prior to joining BlueMountain in 2005, Mr. Markus was a Vice President in the Fixed Income Currency and Commodities Division at Goldman Sachs, trading corporate debt and credit derivatives, including trading single name credit default swaps, credit indices, credit swaptions, convertible asset swaps, synthetic CDO tranches, and corporate warrants. Mr. Markus holds an M.B.A. and B.S. in Economics from the Wharton School at the University of Pennsylvania.

Derek Smith

Managing Partner and Co-Chief Investment Officer

Derek Smith is the Co-Chief Investment Officer and Managing Partner at BlueMountain Capital Management. Mr. Smith is the Chair of the Investment Committee and a member of the Firm’s Management Committee. Prior to joining BlueMountain in 2008, Mr. Smith worked at Deutsche Bank where he was a Managing Director of Global Credit Trading, managing investment grade and high-yield credit cash and derivatives desks for U.S. and Europe. Prior to that, Mr. Smith spent nearly 15 years working in various aspects of the fixed income, derivatives and credit markets at Goldman Sachs, managing the U.S. government options desk as well as the investment grade credit cash and derivative desks. Mr. Smith holds a B.S. in Electrical Engineering from Princeton University.

Michael Liberman

Managing Partner, Chief Operating Officer

Michael Liberman is a Managing Partner and Chief Operating Officer at BlueMountain, overseeing the Firm’s Quantitative Strategy, Technology and Operations teams. Mr. Liberman is a member of the Firm’s Management, Risk, and Valuation Committees. Prior to joining BlueMountain in 2004, Mr. Liberman was a Managing Director and Head of Global Interest Rate Product Strategies at Goldman Sachs, with responsibility for risk analytics and systems, quantitative research and market strategies. Prior to that, he spent six years at J.P. Morgan where he worked with Mr. Feldstein, held a number of senior derivatives technology positions including Head of Global Rates Derivatives Technology and was a lead developer of derivatives risk management systems. Earlier in his career, Mr. Liberman developed analytics for the loan portfolio management group at Citibank and spent time developing database and telecommunication software in Silicon Valley. Mr. Liberman holds a B.A. with the highest honors in Mathematics and an M.A. in Mathematics from Brandeis University. Mr. Liberman also continued his graduate studies in Mathematics at the University of California, Berkeley

David Rubenstein

Managing Partner, Chief Executive Officer Europe and General Counsel

David Rubenstein is a Managing Partner, Chief Executive Officer in Europe and General Counsel at BlueMountain. Mr. Rubenstein is a member of the Firm’s Management, Risk, and Valuation Committees. Prior to joining BlueMountain in 2006, Mr. Rubenstein co-founded Renaissance Integrated Solutions, a municipal infrastructure solutions company, where he was the SVP of Corporate Development and General Counsel.  Prior to that, he was a colleague of Mr. Siderow at McKinsey & Company, where he developed strategic and operational effectiveness opportunities for global financial institutions and media companies. Mr. Rubenstein began his career as a corporate lawyer for Cravath, Swaine & Moore working as underwriter’s counsel for high-yield acquisition-related debt offerings as well as borrower’s counsel for project financings and leveraged lease transactions. Mr. Rubenstein is a member of the ISDA Credit Derivatives Determinations Committee, where BlueMountain holds one of the five buy-side seats. He is also a member of the Invest in Futures Committee of The Prince’s Trust in London.  Mr. Rubenstein holds a J.D. cum laude from Harvard Law School, a Masters in Philosophy from Oxford University and a B.A. summa cum laude in Philosophy from Tufts University, where he was elected to Phi Beta Kappa.

Peter Greatrex

Managing Partner, Head of Private Investments

Peter Greatrex is a Managing Partner and Head of Private Investments at BlueMountain, overseeing the Firm’s fundamental research team. Mr. Greatrex is a member of the Firm’s Investment and Management Committees. Prior to his role as Head of Research, Mr. Greatrex was a fundamental credit portfolio manager at BlueMountain, and from 2008 – 2010 was the head portfolio manager in BlueMountain’s London office. Prior to joining BlueMountain in 2007, Mr. Greatrex spent 10 years at J.P. Morgan Chase where he was an Executive Director, spending time both as a portfolio manager for the investment bank credit portfolio and a credit research analyst. As a portfolio manager, he was responsible for $25 billion+ of loans, CDS and derivatives credit risk. He holds an M.B.A. from the Wharton School of Business and a B.A. in History from Middlebury College.

Jes Staley

Managing Partner

Jes Staley is a Managing Partner of BlueMountain Capital. Mr. Staley is also a member of the Firm’s Management, Investment and Valuation Committees.

Prior to joining BlueMountain in 2013, Mr. Staley spent over thirty years at J.P. Morgan where he was the CEO of J.P. Morgan’s Investment Bank and CEO of J.P. Morgan Asset Management. He was also a member of J.P. Morgan’s Operating and Executive Committees. During his tenure, Mr. Staley led J.P. Morgan’s expansion into alternative investments, including its strategic partnership with Highbridge Capital Management.

Mr. Staley serves on the Board of Directors of the Robin Hood Foundation, Code Advisors, the Board of Trustees of Bowdoin College, the Investor Advisory Committee on Financial Markets of the Federal Reserve Bank of New York and is a member of the Council on Foreign Relations.

Mr. Staley holds a B.A. in Economics from Bowdoin College.